| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $75K | — | +0.0% |
| R&D Expense | $722K | — | +75.7% |
| SG&A Expense | $21.0M | — | +2636.2% |
| Operating Income | -$21.7M | -2144.8% | -6742.4% |
| Net Income | -$22.2M | -170.7% | — |
| EPS (Basic) | -$0.70 | +54.2% | -3600.0% |
| EPS (Diluted) | -$0.70 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $3.0M | — | — |
| Current Assets | $4.2M | +509.9% | +515.2% |
| Total Assets | $4.3M | +116.6% | -51.6% |
| Current Liabilities | $23.5M | +45.5% | +355.7% |
| Total Liabilities | $38.2M | +65.1% | +556.7% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$11.1M | — | — |
| Investing Cash Flow | -$1.0M | — | — |
| Financing Cash Flow | $14.9M | — | — |
| -3600.0% |
| -$34.0M |
| -50.9% |
| -556.2% |